<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03341325</url>
  </required_header>
  <id_info>
    <org_study_id>AAT NIRS</org_study_id>
    <nct_id>NCT03341325</nct_id>
  </id_info>
  <brief_title>Neurovascular Reactions to AAT in Patients With DOC</brief_title>
  <acronym>AAT NIRS</acronym>
  <official_title>Neurovascular Reactions to Animal-assisted Therapy in Patients With Severe Disorders of Consciousness (DOC): a Randomized-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Swiss Tropical &amp; Public Health Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rehab Basel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Basel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Swiss Tropical &amp; Public Health Institute</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is practical evidence but no scientific investigations that persons with severe&#xD;
      disorders of consciousness can profit from animal-assisted therapy regarding their level of&#xD;
      awareness.&#xD;
&#xD;
      The aim of this study is to investigate the effect of animal-assisted therapy on brain&#xD;
      activity of inpatients at REHAB Basel with severe disorders of consciousness.&#xD;
&#xD;
      To do so, the frontal brain activity of 20 the inpatients at REHAB Basel in a minimally&#xD;
      conscious state is investigated via near-infrared spectroscopy (NIRS). Moreover, 20 healthy&#xD;
      participants are included as control subjects.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Each participant will be measured in 6 sessions. Sessions take place three times a week for 2&#xD;
      weeks (leading up to a total of 3 experimental sessions and 3 control sessions), each lasting&#xD;
      for about 15 minutes.&#xD;
&#xD;
      Each session consists of 5 phases, with an animal present in three of them. In the beginning,&#xD;
      waiting (with no stimulus presented) serves as baseline measurement. Second, an animal is&#xD;
      watched, then the animal is placed on the patient's lap and in the fourth condition, the&#xD;
      patient can stroke the animal with the help of the present therapist. After, there is again a&#xD;
      waiting condition.&#xD;
&#xD;
      Control sessions are comparable sessions but with a fur pet instead of a live animal as&#xD;
      stimulus.&#xD;
&#xD;
      Measurements are: brain activity (near-infrared spectroscopy, NIRS), skin conductance (EDA),&#xD;
      heart rate and heart rate variability assessed via photoplethysmography (PPG) during the&#xD;
      sessions and the BAVESTA score after each session. For further behavior analysis all sessions&#xD;
      are videotaped.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Actual">June 28, 2021</completion_date>
  <primary_completion_date type="Actual">June 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Near-infrared spectroscopy (NIRS): oxygenated hemoglobin (O2HB), deoxygenated hemoglobin (HHB), total hemoglobin (HB) and blood oxygen saturation (O2Sat)</measure>
    <time_frame>2 weeks</time_frame>
    <description>All parameters are measured in mmol/ml throughout the sessions, measured via NONIN SenSmart</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Galvanic Skin Response</measure>
    <time_frame>2 weeks</time_frame>
    <description>GSR is measured throughout the sessions via ERPrec, an EEG and ERP recording Software. Skin conductance is measured in Î¼mho.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Heart rate / heart rate variability</measure>
    <time_frame>2 weeks</time_frame>
    <description>Assessed via ERPrec (photoplethysmography (PPG))</description>
  </other_outcome>
  <other_outcome>
    <measure>Basel Vegetative State Assessment (BAVESTA)</measure>
    <time_frame>2 weeks</time_frame>
    <description>The BAVESTA generates a score to assess function deficits in patients with severe disorders of consciousness. The scale ranges from 0 to 5 in total with a higher score indicating higher functioning in patients.&#xD;
Subscales of vegetative regulation, attention, orientation, emotional reactivity, verbal and nonverbal communication, motor activity and information processing are reported.</description>
  </other_outcome>
  <other_outcome>
    <measure>Behavioral coding in Noldus Observer</measure>
    <time_frame>2 weeks</time_frame>
    <description>All sessions are videotaped and then analyzed via behavioral coding and quantified as count variables. The variables motor activity, eye gaze, emotional reactions and communication are presented as the total number of displayed behavior percentaged to the duration of a session.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Consciousness Disorder</condition>
  <condition>Brain Injuries</condition>
  <arm_group>
    <arm_group_label>animal-assisted intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the intervention is a real animal is presented in different forms to the participants</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the control intervention is a stuffed toy animal is presented in different forms to the participants</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>animal-assisted activity</intervention_name>
    <description>a live animal (small dog and/or rabbit)</description>
    <arm_group_label>animal-assisted intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control activity</intervention_name>
    <description>a stuffed toy animal</description>
    <arm_group_label>control intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for patients:&#xD;
&#xD;
          -  Informed Consent as documented by signature (Appendix Informed Consent Form)&#xD;
&#xD;
          -  Inpatients of REHAB Basel with severe disorder of consciousness: minimal conscious&#xD;
             state defined via: Glasgow Coma Scale (GCS) / Coma Recovery Scale-Revised (Koma&#xD;
             Remissions Skala, KRS/KRS-S) / BAVESTA Score&#xD;
&#xD;
          -  Minimum Age of 18 years&#xD;
&#xD;
        Inclusion Criteria for healthy participants:&#xD;
&#xD;
          -  Informed Consent as documented by signature (Appendix Informed Consent Form)&#xD;
&#xD;
          -  History of acquired brain-injury&#xD;
&#xD;
          -  Minimum age of 18 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Enrolment of the investigator, his/her family members, employees and other dependent&#xD;
             persons,&#xD;
&#xD;
          -  medical contraindications for contact with animals as allergy, phobia etc.&#xD;
&#xD;
          -  If the patient's medication changes radically during the time of data collection (only&#xD;
             eligible for clinical participants)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karin Hediger, Dr. phil.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Swiss TPH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>REHAB Basel</name>
      <address>
        <city>Basel</city>
        <zip>4012</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>October 4, 2017</study_first_submitted>
  <study_first_submitted_qc>November 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2017</study_first_posted>
  <last_update_submitted>September 23, 2021</last_update_submitted>
  <last_update_submitted_qc>September 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>animal-assisted therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Consciousness Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

